These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32427693)

  • 1. Fibroblast growth factor receptor as a potential candidate for phosphate sensing.
    Takashi Y; Fukumoto S
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):446-452. PubMed ID: 32427693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate-sensing and regulatory mechanism of FGF23 production.
    Takashi Y; Fukumoto S
    J Endocrinol Invest; 2020 Jul; 43(7):877-883. PubMed ID: 32140858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphate-sensing mechanisms and functions of phosphate as a first messenger.
    Takashi Y
    Endocr J; 2024 Apr; 71(4):335-343. PubMed ID: 38556320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate-Sensing.
    Takashi Y; Fukumoto S
    Adv Exp Med Biol; 2022; 1362():27-35. PubMed ID: 35288870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation.
    Takashi Y; Kosako H; Sawatsubashi S; Kinoshita Y; Ito N; Tsoumpra MK; Nangaku M; Abe M; Matsuhisa M; Kato S; Matsumoto T; Fukumoto S
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11418-11427. PubMed ID: 31097591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do we sense phosphate to regulate serum phosphate level?
    Fukumoto S; Takashi Y; Tsoumpra MK; Sawatsubashi S; Matsumoto T
    J Bone Miner Metab; 2020 Jan; 38(1):1-6. PubMed ID: 31797064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
    Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.
    Sneddon WB; Ruiz GW; Gallo LI; Xiao K; Zhang Q; Rbaibi Y; Weisz OA; Apodaca GL; Friedman PA
    J Biol Chem; 2016 Sep; 291(36):18632-42. PubMed ID: 27432882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
    Fukumoto S
    Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23 beyond Phosphotropic Hormone.
    Takashi Y; Fukumoto S
    Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
    Du E; Xiao L; Hurley MM
    J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells.
    Yamazaki M; Ozono K; Okada T; Tachikawa K; Kondou H; Ohata Y; Michigami T
    J Cell Biochem; 2010 Dec; 111(5):1210-21. PubMed ID: 20717920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
    Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
    Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.